PRICE T ROWE ASSOCIATES INC /MD/
Position in ADPT — Adaptive Biotechnologies Corp
CIK 80255
BALTIMORE, MD
Position in ADPT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$21,739,035
-$49,511,707 QoQ
Shares Held
1,566,213
-64.3% QoQ
Ownership
0.979%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $13,532,353,094 across 31 Diagnostics & Research names. ADPT ranks #18 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
6,315,471 | $3,104,243,460 | |
| 2 | DHR |
Danaher Corp /De/
|
15,352,887 | $2,910,907,374 | |
| 3 | NTRA |
Natera, Inc.
|
12,184,876 | $2,436,853,350 | |
| 4 | DGX |
Quest Diagnostics Inc
|
6,297,987 | $1,234,279,491 | |
| 5 | RVTY |
Revvity, Inc.
|
10,090,158 | $883,998,742 | |
| 6 | GH |
Guardant Health, Inc.
|
7,023,689 | $648,778,152 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
305,763 | $385,628,295 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
638,063 | $358,521,218 |
All Filings in ADPT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,739,035 | 1,566,213 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $71,250,742 | 4,387,361 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $16,272,380 | 1,087,726 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,423,653 | 122,202 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $739,002 | 99,462 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $562,882 | 93,892 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $818,293 | 159,823 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $574,881 | 158,807 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $498,285 | 155,229 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,435,131 | 292,884 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $1,682,692 | 308,751 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $10,382,328 | 1,547,292 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $15,531,519 | 1,758,949 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $14,045,879 | 1,838,466 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $13,471,637 | 1,892,084 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $98,567,710 | 12,183,895 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $172,339,173 | 12,416,367 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $372,825,166 | 13,286,713 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $389,057,085 | 11,446,222 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $448,107,166 | 10,966,891 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $387,471,298 | 9,624,225 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $352,105,904 | 5,954,776 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $186,758,554 | 3,840,398 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $131,756,785 | 2,723,373 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $91,771,785 | 3,303,520 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||